Microencapsulated chitosan nanoparticles for lung protein delivery

Ahsan, 2002, Targeting to macrophages: role of physicochemical properties of particulate carriers–liposomes and microspheres–on the phagocytosis by macrophages, J. Control. Release, 79, 29, 10.1016/S0168-3659(01)00549-1

Akhtar, 1997, Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres, Int. J. Pharm., 151, 57, 10.1016/S0378-5173(97)04887-4

Artursson, 1994, Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2), Pharm. Res., 11, 1358, 10.1023/A:1018967116988

Borchard, 1996, The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption III: Effects of chitosan glutamate and carbomer on epithelial tight junctions in vitro, J. Control. Release, 39, 131, 10.1016/0168-3659(95)00146-8

Bosquillon, 2001, Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance, J. Control. Release, 70, 329, 10.1016/S0168-3659(00)00362-X

Bosquillon, 2001, Comparison of particle sizing techniques in the case of inhalation dry powders, J. Pharm. Sci., 90, 2032, 10.1002/jps.1154

Broadhead, 1992, The spray drying of pharmaceuticals, Drug Dev. Ind. Pharm., 18, 1169, 10.3109/03639049209046327

Calvo, 1997, Novel hydrophilic Chitosan–Polyethylene Oxide nanoparticles as protein carriers, J. Appl. Polym. Sci., 63, 125, 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4

Calvo, 1997, Effect of lysozyme on the stability of polyester nanocapsules and nanoparticles: stabilization approaches, Biomaterials, 18, 1305, 10.1016/S0142-9612(97)00061-6

Chidavaenzi, 1997, The use of thermal techniques to assess the impact of feed concentration on the amorphous content and polymorphic forms present in spray dried lactose, Int. J. Pharm., 159, 67, 10.1016/S0378-5173(97)00272-X

Chidavaenzi, 2001, The effect of co-spray drying with polyethyleneglycol 4000 on the crystallinity and physical form of lactose, Int. J. Pharm., 216, 43, 10.1016/S0378-5173(00)00693-1

Clark, 2002, Formulation of proteins and peptides for inhalation, Drug Deliv. Syst. Sci., 2, 73

Courrier, 2002, Pulmonary drug delivery systems: recent developments and prospects, Crit. Rev. Ther. Drug Carrier Syst., 19, 425, 10.1615/CritRevTherDrugCarrierSyst.v19.i45.40

De Campos, 2001, Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cylosporin A, Int. J. Pharm., 224, 159, 10.1016/S0378-5173(01)00760-8

Dornish, 1997, Safety of Protasan™: Ultrapure chitosan salts for biomedical and pharmaceutical use, 664

Duszyk, 2001, CFTR and lysozyme secretion in human airway epithelial cells, Eur. J. Physiol., 443, S45, 10.1007/s004240100643

El-Gibaly, 2002, Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres, Int. J. Pharm., 294, 7, 10.1016/S0378-5173(02)00396-4

Evora, 1998, Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine, J. Control. Release, 51, 143, 10.1016/S0168-3659(97)00149-1

Fernández-Urrusuno, 1999, Enhancement of nasal absorption of insulin using chitosan nanoparticles, Pharm. Res., 16, 1576, 10.1023/A:1018908705446

Fernández-Urrusuno, 1999, Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration, STP Pharm. Sci., 9, 429

Finlay, 2000, Inertial sizing of aerosol inhaled from two dry powder inhalers with realistic breath patterns versus constant flow rates, Int. J. Pharm., 210, 83, 10.1016/S0378-5173(00)00569-X

Finlay, 1997, Fine particle fraction as a measure of mass depositing in the lung during inhalation of nearly isotonic nebulized aerosols, J. Aerosol Sci., 28, 1301, 10.1016/S0021-8502(97)00017-7

Gehr, 1996, Airway surfactant, a primary defence barrier: mechanical and immunological aspects, J. Aerosol Med., 9, 163, 10.1089/jam.1996.9.163

Heinemann, 2000, Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer, Diabetes Care, 23, 1343, 10.2337/diacare.23.9.1343

Heyder, 1986, Deposition of particles in the human respiratory tract in the size range 0.005–15μm, J. Aerosol Sci., 17, 811, 10.1016/0021-8502(86)90035-2

Hirano, 1988, Biocompatibility of chitosan by oral and intravenous administrations, Polym. Mater. Sci. Eng., 59, 897

Kawashima, 1998, A new powder design method to improve inhalation efficiency of pranlukast hydrate dry powder aerosols by surface modification with hydroxypropylmethylcellulose phthalate nanospheres, Pharm. Res., 15, 1748, 10.1023/A:1011916930655

Konstan, 1981, Human lung lysozyme: sources and properties, Am. Rev. Respir. Dis., 123, 120

Kyle, 1990, Control of pH of airway surface liquid of the ferret trachea in vitro, J. Appl. Physiol., 68, 135, 10.1152/jappl.1990.68.1.135

Lehr, 1992, In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers, Int. J. Pharm., 78, 43, 10.1016/0378-5173(92)90353-4

Makino, 2003, Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres, Colloids Surf., B: Biointerfaces, 27, 33, 10.1016/S0927-7765(02)00042-5

Muzzarelli, 1985, Chitin, 3, 417

Muzzarelli, 1997, Human enzymatic activities related to the therapeutic administration of chitin derivatives, Cell. Mol. Life Sci., 53, 131, 10.1007/PL00000584

Patton, 1992, Pulmonary delivery of peptides and proteins for systemic action, Adv. Drug Deliv. Rev., 8, 179, 10.1016/0169-409X(92)90002-8

Pohlmann, 2002, Spray-dried indomethacin-loaded polyester nanocapsules and nanospheres: development, stability evaluation and nanostructure models, Eur. J. Pharm. Sci., 16, 305, 10.1016/S0928-0987(02)00127-6

Portero, 2002, The potential of chitosan in enhancing peptide and protein absorption across the TR146 cell culture model – an in vitro model of the buccal epithelium, Pharm. Res., 19, 169, 10.1023/A:1014220832384

Rios, 1994, Administración nasal e inhalatoria, 131

Rudt, 1992, In vitro phagocytosis of nano- and microparticles by chemiluminescence. I. Effect of analytical parameters, particle size and particle concentration, J. Control. Release, 22, 263, 10.1016/0168-3659(92)90101-V

Schurch, 1990, Surfactant displaces particles toward the epithelium in airways and alveoli, Respir. Physiol., 80, 17, 10.1016/0034-5687(90)90003-H

Sham, 2004, Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung, Int. J. Pharm., 269, 457, 10.1016/j.ijpharm.2003.09.041

Taylor, 2001, Pulmonary drug delivery, 269

Tsapis, 2002, Trojan particles: large porous carriers of nanoparticles for drug delivery, Proc. Natl. Acad. Sci., 99, 12001, 10.1073/pnas.182233999

Walters, 2002, Lung lining liquid – The hidden depths, Biol. Neonate, 81, S2, 10.1159/000056764

Williams, 1998, Investigation of a pMDI system containing chitosan microspheres and P134a, Int. J. Pharm., 174, 209, 10.1016/S0378-5173(98)00266-X